China Universal Asset Management Company’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
IGAM
AA
MAP
PFSRSONJ
PCM
PPWP
SO
PR
China Universal Asset Management Company's AMLX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Amylyx Pharmaceuticals (AMLX) stake by 9.2% in Q2 2026, selling an estimated $27.7K and leaving 17,695 shares worth $318K. The position accounts for 0.02% of the portfolio, ranked #310.
China Universal Asset Management Company first reported a position in AMLX in Q4 2022 and has held it in 15 quarters since. 27 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.
- China Universal Asset Management Company held 17,695 shares of Amylyx Pharmaceuticals worth $318K as of Q2 2026.
- China Universal Asset Management Company sold 1,793 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $27.7K.
- Amylyx Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #310 holding.
- China Universal Asset Management Company first reported a position in Amylyx Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
- 27 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.